Cargando…
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
Advances within cancer immunotherapy have fueled a paradigm shift in cancer treatment, resulting in increasing numbers of cancer types benefitting from novel treatment options. Despite originally being considered an immunologically silent malignancy, recent studies encourage the research of breast c...
Autores principales: | Viborg, Nadia, Ramskov, Sofie, Andersen, Rikke Sick, Sturm, Theo, Fugmann, Tim, Bentzen, Amalie Kai, Rafa, Vibeke Mindahl, Straten, Per thor, Svane, Inge Marie, Met, Özcan, Hadrup, Sine Reker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844330/ https://www.ncbi.nlm.nih.gov/pubmed/31741759 http://dx.doi.org/10.1080/2162402X.2019.1663107 |
Ejemplares similares
-
High frequency of T cells specific for cryptic epitopes in melanoma patients
por: Andersen, Rikke Sick, et al.
Publicado: (2013) -
Broadening the repertoire of melanoma-associated T-cell epitopes
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015) -
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
por: Ellebaek, Eva, et al.
Publicado: (2012) -
Evolution of MHC-based technologies used for detection of antigen-responsive T cells
por: Bentzen, Amalie Kai, et al.
Publicado: (2017) -
T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation
por: Bentzen, Amalie Kai, et al.
Publicado: (2019)